ONCE - Spark Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.94B
Enterprise Value 33.68B
Trailing P/E N/A
Forward P/E 1-21.73
PEG Ratio (5 yr expected) 1-1.08
Price/Sales (ttm)67.76
Price/Book (mrq)9.81
Enterprise Value/Revenue 363.24
Enterprise Value/EBITDA 6-16.41

Trading Information

Stock Price History

Beta (3Y Monthly) 1.37
52-Week Change 382.06%
S&P500 52-Week Change 32.99%
52 Week High 3114.20
52 Week Low 334.53
50-Day Moving Average 3101.03
200-Day Moving Average 3105.53

Share Statistics

Avg Vol (3 month) 3428.18k
Avg Vol (10 day) 3533.67k
Shares Outstanding 538.49M
Float 37.69M
% Held by Insiders 17.45%
% Held by Institutions 192.25%
Shares Short (Aug 15, 2019) 42.96M
Short Ratio (Aug 15, 2019) 49.13
Short % of Float (Aug 15, 2019) 47.91%
Short % of Shares Outstanding (Aug 15, 2019) 47.69%
Shares Short (prior month Jul 15, 2019) 43.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-400.46%

Management Effectiveness

Return on Assets (ttm)-19.10%
Return on Equity (ttm)-46.93%

Income Statement

Revenue (ttm)58.14M
Revenue Per Share (ttm)1.53
Quarterly Revenue Growth (yoy)-46.40%
Gross Profit (ttm)56.81M
EBITDA -224.01M
Net Income Avi to Common (ttm)-231.2M
Diluted EPS (ttm)-6.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)400.84M
Total Cash Per Share (mrq)10.41
Total Debt (mrq)138.01M
Total Debt/Equity (mrq)34.36
Current Ratio (mrq)5.56
Book Value Per Share (mrq)10.44

Cash Flow Statement

Operating Cash Flow (ttm)-156.87M
Levered Free Cash Flow (ttm)-148M